Stock Events

HST Global 

$1.04
1
+$0+0% Wednesday 20:00

Statistics

Day High
1.04
Day Low
1.04
52W High
1.15
52W Low
0.35
Volume
100
Avg. Volume
102
Mkt Cap
43.64M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.02
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.0067

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSTC. It's not an investment recommendation.
Alphabet
78096
GOOGL
Apple
67979
AAPL
Microsoft
63406
MSFT
Amazon
59137
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap179.38B
Amgen is a biotechnology firm involved in the development of treatments that could potentially compete with HST Global's cancer therapies.
Gilead Sciences
GILD
Mkt Cap98.35B
Gilead Sciences operates in the biopharmaceutical field focusing on drugs, including cancer treatments, which could directly compete with HST Global's products.
Merck
MRK
Mkt Cap300.25B
Merck is a global healthcare company that produces cancer drugs and therapies, competing in the same market as HST Global.
Pfizer
PFE
Mkt Cap164.39B
Pfizer is involved in the development and manufacturing of healthcare products, including cancer treatments, which positions them as a competitor to HST Global.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol-Myers Squibb specializes in biopharmaceuticals, including cancer drugs, competing in the oncology sector with HST Global.
Novartis
NVS
Mkt Cap244.75B
Novartis is a multinational pharmaceutical company that develops and sells drugs, including those for cancer, which competes with HST Global's offerings.
Lilly(Eli) &
LLY
Mkt Cap864.43B
Eli Lilly and Company develops pharmaceutical products, including cancer treatments, which makes them a direct competitor to HST Global.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson operates in the healthcare sector, offering products and treatments for various diseases, including cancer, competing with HST Global.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie is a biopharmaceutical company that develops and markets therapies, including for cancer, which competes with HST Global.
Roche
RHHBY
Mkt Cap272.83B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including cancer treatments, directly competing with HST Global in the oncology market.

About

Miscellaneous Commercial Services
Commercial Services
Health Services
Hospital/Nursing Management
Manufacturing
Pharmaceutical Preparation Manufacturing
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
Show more...
CEO
Country
US
ISIN
US40432E2028

Listings

US
HSTC